Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
|Publication date:||25th June 2010|
|Author:||Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease, Institute of Medicine, Board on Health Scie|
|Publisher:||National Academies Press|
|Categories:||Diseases & disorders,|